Evidence map›Paper›PMID 39702763›Full record

ArticleNPJ biofilms and microbiomes2024

Diverse polysaccharide production and biofilm formation abilities of clinical Klebsiella pneumoniae.

Robert L Beckman, Elenora Cella, Taj Azarian, Olaya Rendueles, Renee M Fleeman

Abstract read
In one paragraph

Article in NPJ biofilms and microbiomes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Biofilm-Forming Capacity andAntibiotics (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The acquisition ofmBio · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The acquisition ofbioRxiv : the preprint server for biology · 2025
    Article
  15. UropathogenicMicroorganisms · 2025
    Article
  16. Article
  17. One health (Amsterdam, Netherlands) · 2025
    Article
  18. Molecular epidemiology of carbapenem-resistantFrontiers in microbiology · 2025
    Article
  19. TheFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Robert L BeckmanBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
Elenora CellaBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.ORCID http://orcid.org/0000-0002-7870-9744
Taj AzarianBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.ORCID http://orcid.org/0000-0002-8611-5241
Olaya RenduelesLaboratoire de Microbiologie et Génétique Moléculaires (LMGM), UMR5100, Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, France.ORCID http://orcid.org/0000-0002-6648-1594
Renee M FleemanBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA. Renee.Fleeman@ucf.edu.ORCID http://orcid.org/0000-0001-7103-461X

Funding

Refining our understanding of antimicrobial peptide mediated disruption of the Klebsiella pneumoniae capsuleR00AI163295 · NIAID · UNIVERSITY OF CENTRAL FLORIDA · PI FLEEMAN, RENEE · 2023 to 2025
$747k
Agence Nationale de la Recherche (French National Research Agency) ANR 22 CE20 00181 BETinCAPDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) R00AI163295NIAID NIH HHS R00 AI163295
6 · The paper itself

Abstract

Klebsiella pneumoniae infections have become a growing threat for human health. The lack of understanding of the relationship between antibiotic resistance, mucoviscosity, and biofilm formation impedes our abilities to effectively predict K. pneumoniae infection outcomes. The Multidrug-Resistant Organism Repository and Surveillance Network offers a unique opportunity into the genetic and phenotypic variabilities in the K. pneumoniae isolates. To this end, we compared the genetic profiles of these isolates with the phenotypic biofilm formation, percent mucoviscosity, and growth rates. There was a significant phenotype-genotype correlation with decreased biofilm formation and an insertion sequence in the transcriptional activator of the type III fimbrial system. Interestingly, the most mucoid strains in the populations were lacking the genetic element regulating the mucoid phenotype and three of these isolates were able to form robust biofilms. The combination of phenotypic, genomic, and image analyses revealed an intricate relation between growth, mucoviscosity and specific virulence-associated genetic determinants.

Indexed as

BiofilmsKlebsiella InfectionsKlebsiella pneumoniaePolysaccharides, BacterialDrug Resistance, Multiple, BacterialGene Expression Regulation, BacterialGenotypeHumansPhenotypeVirulencePolysaccharides, Bacterial

Identifiers

PMID39702763
PMCPMC11659406

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.